Active endothelial and neural regulation of valve biology, health, and disease
-
By
-
G. Janani
-
Kenny L. Nguyen
-
Jonathan T. Butcher
-
May 29, 2026
-
Clinical Scorecard: Dynamic Regulation of Cardiac Valve Biology and Pathophysiology by Endothelial and Neural Mechanisms
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Adults, particularly those ≥65 years of age, with a focus on aortic stenosis prevalence. |
| Care Setting | |
Key Highlights
- Valves are dynamic structures responding to hemodynamic forces.
- Calcific aortic valve disease (CAVD) and degenerative mitral valve disease (DMVD) are prevalent.
- Lymphatic vessels and nerve fibers play critical roles in valve homeostasis.
- Current pharmacological therapies are not approved for slowing or reversing valve disease.
- Aortic stenosis prevalence increases with age, affecting 25% of adults ≥65 years.
- Valvular heart disease is often underdiagnosed; early detection is crucial.
Guideline-Based Recommendations
Diagnosis
- Valvular heart disease is often underdiagnosed; early detection is crucial.
Management
- Interventions typically occur late in the disease course, often after irreversible damage.
Monitoring & Follow-up
- Regular assessment of valve function in at-risk populations is recommended.
Risks
- Increased mechanical stress and age are significant risk factors for aortic stenosis.
Patient & Prescribing Data
Ataciguat shows promise in early-phase studies but lacks approval.
Clinical Best Practices
- Integrate endothelial, lymphatic, and neural components into valve biology understanding.
- Consider biomechanical factors in the management of aortic stenosis.
Related Resources & Content
